Th17 alloimmunity prevents neonatal establishment of lymphoid chimerism in IL-4-deprived mice

American Journal of Transplantation

Volumn 12, Issue 1, 2012, Pages 81-89

  Debock, I ^a   Delbauve, S ^a   Dubois, A ^a   Petein M ^a   Leo, O ^a   Goldman, M ^a   Flamand, V ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

chimerism; IL 4; neonates; Th17; tolerance

Indexed keywords

ALLOANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CHIMERA; CYTOKINE PRODUCTION; GRAFT REJECTION; IMMUNIZATION; LYMPHOID CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SKIN ALLOGRAFT; SKIN GRAFT; SKIN TRANSPLANTATION; SPLEEN CELL; TH17 CELL;

ANIMALS; ANIMALS, NEWBORN; CHIMERISM; INTERLEUKIN-17; INTERLEUKIN-4; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 84855980146     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03778.x     Document Type: Article

References (42)

1. Billingham RE, Brent L, Medawar PB,. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603-606.
2. Abramowicz D, Vandervorst P, Bruyns C, Doutrelepont JM, Vandenabeele P, Goldman M,. Persistence of anti-donor allohelper T cells after neonatal induction of allotolerance in mice. Eur J Immunol 1990; 20: 1647-1653. (Pubitemid 20290895)
3. Powell TJ Jr., Streilein JW,. Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells. J Immunol 1990; 144: 854-859. (Pubitemid 20065023)
4. Schurmans S, Heusser CH, Qin HY, Merino J, Brighouse G, Lambert PH,. In vivo effects of anti-IL-4 monoclonal antibody on neonatal induction of tolerance and on an associated autoimmune syndrome. J Immunol 1990; 145: 2465-2473. (Pubitemid 20374565)
5. Adkins B, Leclerc C, Marshall-Clarke S,. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004; 4: 553-564. (Pubitemid 38931770)
6. Rose S, Lichtenheld M, Foote MR, Adkins B,. Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function. J Immunol 2007; 178: 2667-2678. (Pubitemid 46333143)
7. Li L, Lee HH, Bell JJ, et al,. IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2. Immunity 2004; 20: 429-440. (Pubitemid 38482121)
8. Lee HH, Hoeman CM, Hardaway JC, et al,. Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J Exp Med 2008; 205: 2269-2280.
9. Donckier V, Wissing M, Bruyns C, et al,. Critical role of interleukin 4 in the induction of neonatal transplantation tolerance. Transplantation 1995; 59: 1571-1576.
10. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA,. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007; 27: 647-659. (Pubitemid 47615503)
11. Zheng Y, Danilenko DM, Valdez P, et al,. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445: 648-651. (Pubitemid 46232884)
12. Bettelli E, Carrier Y, Gao W, et al,. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238.
13. Mangan PR, Harrington LE, O'Quinn DB, et al,. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441: 231-234.
14. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B,. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179-189. (Pubitemid 43214587)
15. Ivanov, II, McKenzie BS, Zhou L, et al,. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126: 1121-1133. (Pubitemid 44380299)
16. Kolls JK, Linden A,. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467-476. (Pubitemid 39370503)
17. Surquin M, Le Moine A, Flamand V, et al,. IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts. Transplantation 2005; 80: 1485-1492. (Pubitemid 41803632)
18. Flamand V, Donckier V, Demoor FX, et al,. CD40 ligation prevents neonatal induction of transplantation tolerance. J Immunol 1998; 160: 4666-4669. (Pubitemid 28215298)
19. Adams B, Nagy N, Paulart F, Vanderhaeghen ML, Goldman M, Flamand V,. CD8+ T lymphocytes regulating Th2 pathology escape neonatal tolerization. J Immunol 2003; 171: 5071-5076. (Pubitemid 37432788)
20. Donckier V, Flamand V, Desalle F, et al,. IL-12 prevents neonatal induction of transplantation tolerance in mice. Eur J Immunol 1998; 28: 1426-1430.
21. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM,. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 1990; 171: 115-127. (Pubitemid 20040603)
22. Harrington LE, Hatton RD, Mangan PR, et al,. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132. (Pubitemid 41541790)
23. Park H, Li Z, Yang XO, et al,. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141. (Pubitemid 41541791)
24. Schnyder-Candrian S, Togbe D, Couillin I, et al,. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 2006; 203: 2715-2725. (Pubitemid 44833347)
25. van Hamburg JP, de Bruijn MJ, Ribeiro de Almeida C, et al,. Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology. Eur J Immunol 2008; 38: 2573-2586.
26. Zhu J, Davidson TS, Wei G, et al,. Down-regulation of Gfi-1 expression by TGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells. J Exp Med 2009; 206: 329-341.
27. Newcomb DC, Zhou W, Moore ML, et al,. A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production. J Immunol 2009; 182: 5317-5321.
28. Hofstetter HH, Kovalovsky A, Shive CL, Lehmann PV, Forsthuber TG,. Neonatal induction of myelin-specific Th1/Th17 immunity does not result in experimental autoimmune encephalomyelitis and can protect against the disease in adulthood. J Neuroimmunol 2007; 187: 20-30. (Pubitemid 47001534)
29. Das J, Ren G, Zhang L, et al,. Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med 2009; 206: 2407-2416.
30. Gao Q, Rouse TM, Kazmerzak K, Field EH,. CD4+CD25+ cells regulate CD8 cell anergy in neonatal tolerant mice. Transplantation 1999; 68: 1891-1897. (Pubitemid 30027343)
31. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, et al,. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 2008; 205: 3133-3144.
32. Vokaer B, Van Rompaey N, Lemaitre PH, et al,. Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection. J Immunol 2010; 185: 3417-3425.
33. Carlson MJ, West ML, Coghill JM, Panoskaltsis-Mortari A, Blazar BR, Serody JS,. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 2009; 113: 1365-1374.
34. Kappel LW, Goldberg GL, King CG, et al,. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 2009; 113: 945-952.
35. Chen L, Ahmed E, Wang T, et al,. TLR signals promote IL-6/IL-17-dependent transplant rejection. J Immunol 2009; 182: 6217-6225.
36. Donckier V, Abramowicz D, Bruyns C, et al,. IFN-gamma prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice. J Immunol 1994; 153: 2361-2368.
37. Donckier V, Flamand V, Abramowicz D, Goldman M,. Dissociation between chimerism and skin graft tolerance after neonatal injection of allogenic spleen cells. Transplant Proc 1998; 30: 4018-4019. (Pubitemid 29013140)
38. Hirano T, Yasukawa K, Harada H, et al,. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986; 324: 73-76. (Pubitemid 16008419)
39. Merluzzi S, Frossi B, Gri G, Parusso S, Tripodo C, Pucillo C,. Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells. Blood 2010; 115: 2810-2817.
40. Martin-Orozco N, Muranski P, Chung Y, et al,. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 2009; 31: 787-798.
41. Adkins B, Jones M, Bu Y, Levy RB,. Neonatal tolerance revisited again: specific CTL priming in mouse neonates exposed to small numbers of semi- or fully allogeneic spleen cells. Eur J Immunol 2004; 34: 1901-1909. (Pubitemid 39256072)
42. Le Moine A, Flamand V, de Lavareille A, et al,. Hypereosinophilic syndrome induced by neonatal immunization against MHC class II alloantigen: critical role of IL-4. Eur J Immunol 2002; 32: 174-181. (Pubitemid 34092835)